Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Size By Technology (SNP Microarrays, TaqMan SNP Genotyping, Sequencing Technology), By Application (Diagnostics, Animal, Plant, and Research), By Geographic Scope And Forecast

Middle East Single Nucleotide Polymorphism Genotyping Market Size And Forecast

The market size of SNP genotyping stood at USD 633.71 million in 2020 and is projected to reach USD 2,252.14 million, by 2028. The market in Saudi Arabia is expected to grow with a CAGR of 18.9% during the forecast period (2021-2028).

The Middle East SNP market is driven by growing fatal diseases and growing expenditure on the research and development sector. The growing educational institutes in the region are propelling market growth. The Middle East Single Nucleotide Polymorphism Genotyping Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Middle East Single Nucleotide Polymorphism Genotyping Market Definition

Single Nucleotide Polymorphism (SNP) Genotyping is the method of detecting as well as genotyping single nucleotide polymorphisms, which are DNA sequence variations that ascend when a change in one nucleotide results in a diverse allele. SNP analysis has become an interesting and suitable technique to study DNA sequence variations. The SNP Genotyping market is expected to notice a development rate as more microarrays with more DNA probes enter the market. SNP genotyping is extremely effective and comparatively more expensive than conventional time consuming, expensive as well as labor extensive detection technology. Automated Analysis of SNP genotyping is extensively used in diverse disciplines of genetics and associated studies, usually related to studying genetic determinants of numerous complex diseases. SNP genotyping technologies are widely helpful in the etiology of numerous human diseases such as cardiovascular, cancer, Alzheimer’s, asthma, and others.

SNP genotyping is an upcoming area of interest for researchers for life science as well as genomics studies and it has a wide range of applications in several industries like research, agricultural biotechnological, pharmaceuticals, and others which leads to changes in dairy, Middle East as well as crop yields. The usage of SNP genotyping is rising quickly from modified genetic testing to plant as well as animal biotechnology. Single Nucleotide Polymorphism Genotyping gives an idea about the human genome characterization and transfer of genetic diseases. As it predicts disease association together with the response of an individual to a particular medicine, Single Nucleotide Polymorphism Genotyping is of great value for the pharmaceutical as well as medical fields. Human SNP genotyping has lots of implications in clinical diagnostics, disease prediction, and treatment, new drug detection as well as enlightening the current practice of medicine. Some of the other factors that drive the market are the rising prevalence of fatal diseases like diabetes, cancer, and others. Moreover, growing demand for genetic analysis in the plant as well as animal feedstock, the existence of private as well as public funding programs in the field of genetics is also empowering the market.

The Middle East SNP Genotyping market is segmented based on technology and application. Based on technology, the market is segmented into SNP Microarrays, TaqMan SNP genotyping, MassARRAY SNP Genotyping, Sequencing Technology, and Others. Also, by application, the market is segmented into Diagnostics, Animal, Plant research, and others. Affymetrix, Bio-rad, Beckman Coulter, Agilent Technologies, Luminex Corporation, Applied Biosystems, Roche, Enzo Life Sciences, Qiagen, BGI. These are some of the key players in the market.

Middle East Single Nucleotide Polymorphism Genotyping Market Overview

Single nucleotide polymorphism genotyping is a research-based industry. In the growing years of growing technology and research and development, the industry is witnessing Middle East growth. However, the low healthcare spending and less developed facility for the R&D sector hampering the market growth. The initiation of COVID caused the various markets to shut down SNP genotyping saw a lucrative growth as it was utilized in COVID detection.

The Middle East SNP market is driven by growing fatal diseases and growing expenditure on the research and development sector. The growing educational institutes in the region are propelling market growth. The increasing pipeline for personalized medicine and novel drug delivery systems, which extensively exploit SNP in genetic materials for drug development applications, is primarily responsible for the large share of pharmacogenomics.

The Middle East SNP Genotyping is segmented based on technology and application. The technology segment is divided into SNP Microarrays, TaqMan SNP Genotyping, MassARRAY SNP Genotyping, Sequencing Technology, and Others. The application is segmented into Diagnostics, Animal, Plant, and Research.

The development of next-generation is a sequencing technology that revolutionizes the field of biology and creates new genetic sequences that help in fighting any disease. The growing research for population genetics, mapping traits and phylogeography is boosting the market growth in the long run.

Researchers have found SNP as an effective method to predict an individual response against any drug and its effect on the environment what are the harmful effect it could cause in developing a response for that particular disease. The growing government initiatives in the field of research and development have boosted the practice for the development of technologies for the good fare of mankind. The advantage of SNP over other genotyping methods is flexible and fast detection and data management. Countries like Saudi Arabia are the major shareholder and accounted for the highest growth which is 18.9% in the forecast period.

Middle East Single Nucleotide Polymorphism Genotyping MarketSegmentation Analysis

The Middle East Single Nucleotide Polymorphism Genotyping Market is segmented on the basis of Technology, Application, and Geography.

Middle East Single Nucleotide Polymorphism Genotyping Market, By Technology

• SNP Microarrays• TaqMan SNP Genotyping• Sequencing Technology• Others

Based on Technology, the market is bifurcated into SNP Microarrays, TaqMan SNP Genotyping, Sequencing Technology, and Others. SNP Microarrays accounted for the largest market share in the FY 2020. SNP microarray technology is the interbreeding of fragmented single-stranded DNA to arrays comprising hundreds of thousands of exclusive nucleotide probe sequences. Individually probe is designed to bind to the target DNA subsequence. The commercially existing arrays for single nucleotide polymorphism genotyping mainly contain Affymetrix SNP as well as Illumina platforms. Affymetrix and Illumina genotyping solutions offer reliable performance regarding agricultural genotyping, precision medicine, population-scale studies, forensics, as well as genome-wide association studies. Commercially available high-density single nucleotide polymorphism chips cover most of the human genome as well as other animals and plants of economic significance.

Middle East Single Nucleotide Polymorphism Genotyping Market, By Application

• Diagnostics• Animal• Plant• Research

To Get Summarized Market Report By Application-

On the basis of Application, the Middle East Single Nucleotide Polymorphism Genotyping Market has been segmented into Diagnostics, Animal, Plant, and Research. Research accounted for the largest market share of 55.25% in 2020, projected to grow at the highest CAGR of 17.65% during the forecast period. Single Nucleotide Polymorphism Genotyping is a method used in the sequencing of nucleic acid molecules. Such sequencing can be done by numerous diverse methods counting capillary electrophoresis, prism, and microarrays. In diagnostic tests, SNP genotyping is frequently used to determine a person’s likelihood of developing certain diseases as well as their response to drugs. SNP genotyping is widely helpful in the etiology of numerous human diseases such as cardiovascular, Alzheimer’s, cancer, asthma, and others. SNP signifies a promising way to study complex as well as common diseases in which numerous genetic variations contribute to a person’s risk. Moreover, this genotyping has already identified SNPs connected to numerous complex conditions counting heart abnormalities, diabetes, Parkinson disease, and Crohn’s disease.

Middle East Single Nucleotide Polymorphism Genotyping Market, By Geography

• Saudi Arabia• UAE• Oman• Turkey• Qatar• Rest of Middle East

To Get Summarized Market Report By Geography- 

On the basis of regional analysis, the Middle East Single Nucleotide Polymorphism Genotyping Market is classified into Saudi Arabia, UAE, Oman, Turkey, Qatar, and Rest of Middle East. Saudi Arabia is the major country contributing largest market share also growth rate in Middle East SNP genotyping market is due to large amount of spending on both drug development and overall healthcare industry.Turkey, UAE, South Africa, Saudi Arabia, and the Rest of the Middle East & Africa constitute the market for drug discovery. There is an upsurge in the implementation of HTS technology in the Middle East and Africa region for numerous drug development processes. The technology is used in lead identification to determine an inhibitor for respiratory syndrome diseases in the Middle East. The growing incidence of diseases such as Alzheimer’s, AID’S and other drug-resistant communicable diseases, has also led to the discovery of new bioactive compounds. These factors have been powering the drug discovery market significantly which further aids to stimulate the market of SNP Genotyping in the region.

Key Players

The “Middle East Single Nucleotide Polymorphism Genotyping Market” study report will provide a valuable insight with an emphasis on the market including some of the major players such as Bio-Rad Laboratories, Agilent Technologies, Thermo Fisher Scientific (Affymetrix) Inc., PerkinElmer, Roche Holding AG, Enzo Life Sciences, Inc., Qiagen, Illumina, Shimadzu Corporation, Waters Corporation. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.

Key Developments

• Thermo Scientific has introduced Differential Ion Mobility Interface to enhance qualitative and quantitative mass spectral workflows.• The Thermo Scientific FAIMS Pro Duo interface builds upon the foundation of the Thermo Scientific FAIMS Pro interface to continue to support biological mass spectrometry (MS) and extend differential ion mobility to a broader range of applications including proteomics, plasma profiling, and targeted small-molecule quantitation.

Report Scope

To Get Customized Report Scope- 

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.